SCHEMBL233540

SCHEMBL233540

CNC(CCc1nc(C[C@H](N)C(=O)O)c[nH]1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 4/20 0.39
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.35
KDM4E B2RXH2 2/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 2/20 0.33
TSHR P16473 2/20 0.33
BLM P54132 2/20 0.33
PMP22 Q01453 2/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
MPO P05164 1/20 0.33
HIF1A Q16665 1/20 0.33
ALPI P09923 1/20 0.32
PKM P14618 1/20 0.32
PTGS1 P23219 1/20 0.32
XIAP P98170 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTR1A P08908 1/20 0.32
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29022786 1.00 SLC7A5 (0.39) SLC7A5CYP3A4CYP1A2KDM4ELMNA
SCHEMBL849757 0.85 SLC7A5 (0.45) SLC7A5CYP3A4CYP1A2KDM4ELMNA
SCHEMBL8001783 0.85 SLC7A5 (0.45) SLC7A5CYP3A4CYP1A2KDM4ELMNA
SCHEMBL30443813 0.83 SLC7A5 (0.41) SLC7A5CYP3A4CYP1A2KDM4ELMNA
SCHEMBL29022742 0.83 SLC7A5 (0.41) SLC7A5CYP3A4CYP1A2KDM4ELMNA
SCHEMBL31369905 0.81 SLC7A5 (0.44) SLC7A5CYP3A4CYP1A2KDM4ELMNA
SCHEMBL4453493 0.79 SLC7A5 (0.36) SLC7A5CYP3A4CYP1A2KDM4ELMNA
SCHEMBL4453499 0.79 SLC7A5 (0.36) SLC7A5CYP3A4CYP1A2KDM4ELMNA
SCHEMBL263447 0.78 SLC7A5 (0.37) SLC7A5CYP3A4CYP1A2KDM4ELMNA
SCHEMBL233541 0.77 SLC7A5 (0.43) SLC7A5CYP3A4ALPIPKMPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116298235-A Serum metabolism biomarker for diagnosing or monitoring breast cancer and screening method thereof 哈尔滨医科大学 2023-06-23 CN claimed
CN-116298235-A Serum metabolism biomarker for diagnosing or monitoring breast cancer and screening method thereof 哈尔滨医科大学 2023-06-23 CN disclosed
EP-2463654-B1 Compositions and methods for modeling saccharomyces cerevisiae metabolism UNIV CALIFORNIA (US) 2020-06-03 EP disclosed
EP-2279417-B1 METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF GEORGIA TECH RES INST (US) 2016-07-20 EP disclosed
EP-2463654-A1 Compositions and methods for modeling saccharomyces cerevisiae metabolism The Regents of The University of California (US) 2012-06-13 EP disclosed
US-8170852-B2 Data structures and methods for modeling Saccharomyces cerevisiae metabolism THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-05-01 US disclosed
EP-2434421-A2 Compositions and methods for modeling saccharomyces cerevisiae metabolism The Regents of The University of California (US) 2012-03-28 EP disclosed
US-20120004854-A1 METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION 2012-01-05 US disclosed
EP-2279417-A1 METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF Georgia Tech Research Corporation (US) 2011-02-02 EP disclosed
US-20100280803-A1 Compositions and Methods for Modeling Saccharomyces cerevisiae Metabolism THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2010-11-04 US disclosed
EP-2230312-A1 Probe compound for detecting and isolating enzymes and means and methods using the same Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2010-09-22 EP disclosed
US-7751981-B2 Articles of manufacture and methods for modeling Saccharomyces cerevisiae metabolism THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-07-06 US disclosed
WO-2009151967-A1 METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2009-12-17 WO disclosed